Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_assertion type Assertion NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_head.
- NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_assertion description "[Current work in translational research seeks to identify epigenetic regulators whose aberrant activity contributes to oncogenesis, including the histone methyltransferases DOT1L and EZH2 and the bromodomain-containing BET family, and to develop drugs that inhibit the aberrant activity of these regulators.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_provenance.
- NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_assertion evidence source_evidence_literature NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_provenance.
- NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_assertion SIO_000772 24571255 NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_provenance.
- NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_assertion wasDerivedFrom befree-2016 NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_provenance.
- NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_assertion wasGeneratedBy ECO_0000203 NP1158225.RAZY_AHm50Bes-TOX2ZyXkyIYMphAgq-PNelEiN5V-yoA130_provenance.